Menu
Home
Forums
New posts
Search forums
What's new
New posts
New profile posts
Latest activity
Members
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Everywhere
Threads
This forum
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Forum Diskusi Untuk Umum
Isu Terkini Seputar Farmakologi
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Info Obat dan Regulator Obat Dunia
Prev
1
…
Go to page
Go
62
63
64
65
66
…
Go to page
Go
126
Next
First
Prev
64 of 126
Go to page
Go
Next
Last
Filters
Show only:
Loading…
F
GDUFA III Reauthorization
FDA
Oct 4, 2022
Replies
0
Views
563
Oct 4, 2022
FDA
F
F
FDA Expands CDER NextGen Portal
FDA
Oct 4, 2022
Replies
0
Views
614
Oct 4, 2022
FDA
F
F
Rare Disease Endpoint Advancement Pilot Program
FDA
Oct 4, 2022
Replies
0
Views
642
Oct 4, 2022
FDA
F
F
Biosimilars | Science and Research
FDA
Oct 4, 2022
Replies
0
Views
555
Oct 4, 2022
FDA
F
F
Size, Shape, and Other Physical Attributes of Generic Tablets and Capsules
FDA
Oct 4, 2022
Replies
0
Views
518
Oct 4, 2022
FDA
F
F
FDA releases important information about risk of COVID-19 due to certain variants not neutralized by Evusheld
FDA
Oct 4, 2022
Replies
0
Views
540
Oct 4, 2022
FDA
F
F
Rare Disease Endpoint Advancement Pilot Program Frequently Asked Questions
FDA
Oct 4, 2022
Replies
0
Views
535
Oct 4, 2022
FDA
F
F
FDA grants accelerated approval to futibatinib for cholangiocarcinoma
FDA
Oct 3, 2022
Replies
0
Views
546
Oct 3, 2022
FDA
F
F
Innovation to Respond to COVID-19
FDA
Oct 3, 2022
Replies
0
Views
567
Oct 3, 2022
FDA
F
F
BD Announces Voluntary Recall of ChloraPrep™ 3 mL Applicator in Specific U.S. Territories and Countries
FDA
Oct 3, 2022
Replies
0
Views
691
Oct 3, 2022
FDA
F
F
PDUFA VI Commitment: Assessment in Support of Sentinel System
FDA
Oct 3, 2022
Replies
0
Views
534
Oct 3, 2022
FDA
F
F
Food and Drug Administration Overdose Prevention Framework
FDA
Oct 3, 2022
Replies
0
Views
527
Oct 3, 2022
FDA
F
E
EMA pilot offers enhanced support to academic and non-profit developers of advanced therapy medicinal products , , 29/09/2022
EMA
Oct 1, 2022
Replies
0
Views
544
Oct 1, 2022
EMA
E
E
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2022, PRAC, 30/09/2022
EMA
Oct 1, 2022
Replies
0
Views
619
Oct 1, 2022
EMA
E
E
New recommendations for terlipressin-containing medicines in the treatment of hepatorenal syndrome, PRAC, 30/09/2022
EMA
Oct 1, 2022
Replies
0
Views
653
Oct 1, 2022
EMA
E
E
Regulatory information – adjusted fees for pharmacovigilance applications from 3 October 2022, , 30/09/2022
EMA
Oct 1, 2022
Replies
0
Views
798
Oct 1, 2022
EMA
E
F
The FDA Compounding Incidents Program: Adverse Events Associated with Compounded Drugs from Outsourcing Facilities | Audio Transcript
FDA
Oct 1, 2022
Replies
0
Views
535
Oct 1, 2022
FDA
F
F
Industry Information and Guidance
FDA
Oct 1, 2022
Replies
0
Views
470
Oct 1, 2022
FDA
F
F
The FDA Compounding Incidents Program: Adverse Events Associated with Compounded Drugs from Outsourcing Facilities
FDA
Oct 1, 2022
Replies
0
Views
520
Oct 1, 2022
FDA
F
F
GDUFA II Enhanced Accountability & Reporting
FDA
Oct 1, 2022
Replies
0
Views
499
Oct 1, 2022
FDA
F
Prev
1
…
Go to page
Go
62
63
64
65
66
…
Go to page
Go
126
Next
First
Prev
64 of 126
Go to page
Go
Next
Last
You must log in or register to post here.
Home
Forums
Forum Diskusi Untuk Umum
Isu Terkini Seputar Farmakologi
Top